Advertisement
Australia markets close in 3 hours 7 minutes
  • ALL ORDS

    7,766.40
    -132.50 (-1.68%)
     
  • ASX 200

    7,516.30
    -125.80 (-1.65%)
     
  • AUD/USD

    0.6380
    -0.0045 (-0.70%)
     
  • OIL

    86.22
    +3.49 (+4.22%)
     
  • GOLD

    2,421.60
    +23.60 (+0.98%)
     
  • Bitcoin AUD

    96,079.05
    -823.99 (-0.85%)
     
  • CMC Crypto 200

    1,239.92
    +354.39 (+37.03%)
     
  • AUD/EUR

    0.6003
    -0.0028 (-0.46%)
     
  • AUD/NZD

    1.0876
    +0.0001 (+0.01%)
     
  • NZX 50

    11,752.02
    -84.02 (-0.71%)
     
  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     
  • FTSE

    7,877.05
    +29.06 (+0.37%)
     
  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     
  • DAX

    17,837.40
    +67.38 (+0.38%)
     
  • Hang Seng

    16,086.19
    -299.68 (-1.83%)
     
  • NIKKEI 225

    36,818.81
    -1,260.89 (-3.31%)
     

Here's Why You Shouldn't Buy the Dip With Illumina Stock

Here's Why You Shouldn't Buy the Dip With Illumina Stock

For example, over the last five years, Illumina's (NASDAQ: ILMN) stock is down nearly 5%. For those who aren't familiar, Illumina is the undisputed king of the gene sequencer hardware market, to where many accept it as a quasi-monopoly. When healthcare systems or research laboratories need to analyze genetic material, the company's devices are the industry's standard, and it has a product in every segment of the market.